How to join?

How to join?

The NCI is ready to expand the number of institutions participating in the CIRB Initiative. Through this expansion the CIRB will continue to develop the program, to explore a greater variety of issues, and to understand and respond to local IRB and investigator practices and concerns.

In order for your IRB to access CIRB review documents and to utilize the facilitated review mechanism, your institution must formally enroll in the Initiative. To join the Initiative, institutions

must have their own functioning IRB;

be actively enrolling patients in Cooperative Group adult Phase 3 clinical trials -or- Pilot, Phase 2 or Phase 3 pediatric clinical trials;

possess a valid assurance (FWA)

Related links:

When your institution is interested in joining, please contact the CIRB Administrative office through one of the methods described on the Contact Page. The enrollment materials can be sent electronically or can be downloaded from this website. The 30-day website access form is available on this website for those interested in joining, but would like to review CIRB approved studies prior to joining.

Email CIRB contact to send your thoughts and questions to the CIRB.

						back to top